Karen M. Marzlin – Cardiac Medications

Three decades of experience in treating patients with cardiology, Karen We will supply you with cutting-edge information-Information about the selection of certain cardiac medications

Karen M. Marzlin – Cardiac Medications

Hemodynamics and Shock

• Physiological factors that influence myocardial performance
• Vasodilators
  • Vasopressors
  • Inotropes
  • Shock: Dopamine versus Norepinephrine
  • Nuances of decompensated heart failure

Risk Factor Optimization

• Statin therapy in primary and secondary prevention
• Other Antilipid agents: when to use what?
• Evaluation of lipid lowering agents in terms of outcomes
  • AIM High
  • Thrive
• There are many options for hypertension drugs
• Resistant hypertension

Atrial Fibrillation

• Antiarrhythmic pharmacology for rate control
• Antiarrhythmic pharmacology for rhythm control
• Clinical implications of potassium channel blocking medications
• Special considerations for Dronedarone and Amiodarone
• Options for anticoagulant medication
  • Fibrinolytics
  • Anticoagulants
  • Antiplatelets

Therapeutic Advances for Acute Coronary Syndrome

• Prasugrel
• Ticagrelor
• Epleranone post-STEMI
• Non-Steroidals
• ASA and CABG
• Contrast nephropathy

Heart Failure

• Optimal loop diuretic dosage and route
• Nesiritide
• OPTIME Trial
• Serelaxin
• RAAS drugs
• Do you have evidence?-Beta-blockers that are based
• Systolic dysfunction: No drugs

The Patient: Putting it all together-The Centered Approach To Pharmacology and Prescribing

Would you like a gift? Karen M. Marzlin – Cardiac Medications
?

Description:

Join Karen M. Marzlin, DNP. RN. CCNS. CCRN.-CMC, CHFN for an informative and practical day that focuses on common cardiac disorders professionals see in their practice and the current medications used to treat them.

Three decades of experience in treating patients with cardiology, Karen We will supply you with cutting-edge information-Edge information about the selection of specific cardiac medications, their desired outcomes, side effects, and drug interactions. You will have a better understanding of the physiological basis of cardiovascular drug therapy. This includes drugs that alter hemodynamic parameters, alter cardiac electrical systems, disrupt the clotting process, as well as medications used to treat various cardiovascular diseases.

Don’t miss this opportunity to keep pace with the ever-The field of cardiac care is changing rapidly and this seminar will provide valuable information to help reduce potential adverse consequences for patients. The seminar will provide you with a holistic view of cardiovascular pharmacology as well as its role in improving the quality and outcomes of your patients’ lives.

Here’s what you’ll get in Karen M. Marzlin – Cardiac Medications